Search Results - "Ekoru, K."

Deriving an optimal threshold of waist circumference for detecting cardiometabolic risk in sub-Saharan Africa by Ekoru, K, Murphy, G A V, Young, E H, Delisle, H, Jerome, C S, Assah, F, Longo–Mbenza, B, Nzambi, J P D, On'Kin, J B K, Buntix, F, Muyer, M C, Christensen, D L, Wesseh, C S, Sabir, A, Okafor, C, Gezawa, I D, Puepet, F, Enang, O, Raimi, T, Ohwovoriole, E, Oladapo, O O, Bovet, P, Mollentze, W, Unwin, N, Gray, W K, Walker, R, Agoudavi, K, Siziya, S, Chifamba, J, Njelekela, M, Fourie, C M, Kruger, S, Schutte, A E, Walsh, C, Gareta, D, Kamali, A, Seeley, J, Norris, S A, Crowther, N J, Pillay, D, Kaleebu, P, Motala, A A, Sandhu, M S

“…Background: Waist circumference (WC) thresholds derived from western populations continue to be used in sub-Saharan Africa (SSA) despite increasing evidence of…”
Get full text

Whole-genome association study of antibody response to Epstein-Barr virus in an African population: a pilot by Sallah, N., Carstensen, T., Wakeham, K., Bagni, R., Labo, N., Pollard, M. O., Gurdasani, D., Ekoru, K., Pomilla, C., Young, E. H., Fatumo, S., Asiki, G., Kamali, A., Sandhu, M., Kellam, P., Whitby, D., Barroso, I., Newton, R.

“…Epstein Barr virus (EBV) infects 95% of the global population and is associated with up to 2% of cancers globally. Immunoglobulin G (IgG) antibody levels to…”
Get full text

H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocol by Ekoru, K., Young, E. H., Adebamowo, C., Balde, N., Hennig, B. J., Kaleebu, P., Kapiga, S., Levitt, N. S., Mayige, M., Mbanya, J. C., McCarthy, M. I., Nyan, O., Nyirenda, M., Oli, J., Ramaiya, K., Smeeth, L., Sobngwi, E., Rotimi, C. N., Sandhu, M. S., Motala, A. A.

“…The burden and aetiology of type 2 diabetes (T2D) and its microvascular complications may be influenced by varying behavioural and lifestyle environments as…”
Get full text

Sociodemographic distribution of non-communicable disease risk factors in rural Uganda: a cross-sectional study by MURPHY, Georgina A V, ASIKI, Gershim, EKORU, Kenneth, NSUBUGA, Rebecca N, NAKIYINGI-MIIRO, Jessica, YOUNG, Elizabeth H, SEELEY, Janet, SANDHUL, Manjinder S, KAMALI, Anatoli

“…Non-communicable diseases (NCDs) are rapidly becoming leading causes of morbidity and mortality in low- and middle-income countries, including those in…”
Get full text

HIV treatment is associated with a twofold higher probability of raised triglycerides: pooled analyses in 21 023 individuals in sub-Saharan Africa by Ekoru, K., Young, E. H., Dillon, D. G., Gurdasani, D., Stehouwer, N., Faurholt-Jepsen, D., Levitt, N. S., Crowther, N. J., Nyirenda, M., Njelekela, M. A., Ramaiya, K., Nyan, O., Adewole, O. O., Anastos, K., Compostella, C., Dave, J. A., Fourie, C. M., Friis, H., Kruger, I. M., Longenecker, C. T., Maher, D. P., Mutimura, E., Ndhlovu, C. E., Praygod, G., Pefura Yone, E. W., Pujades-Rodriguez, M., Range, N., Sani, M. U., Sanusi, M., Schutte, A. E., Sliwa, K., Tien, P. C., Vorster, E. H., Walsh, C., Gareta, D., Mashili, F., Sobngwi, E., Adebamowo, C., Kamali, A., Seeley, J., Smeeth, L., Pillay, D., Motala, A. A., Kaleebu, P., Sandhu, M. S.

“…Background Anti-retroviral therapy (ART) regimes for HIV are associated with raised levels of circulating triglycerides (TGs) in western populations. However,…”
Get full text